We also showed that PEC treatment with TGF-β induced overexpression of ET-1, PDGFb, and FGF2, three factors that may play a key role in PA-SMC growth and PAH development [22]–[24]. The gene discussed is TGFB1; the disease is pulmonary arterial hypertension.